All articles by Shalini Nair
Shalini Nair
Sanofi enlists Thread as decentralised clinical trial provider in new deal
Thread will act as the exclusive provider of DCTs and eCOA technology for the pharma company’s Integrated Patient Platform.
Ukrainian ports pause commercial shipping amid Russian invasion
Maripol mainly processes ships that range between 3,000dwt and 10,000dwt.
Bio-Thera Solutions begins dosing in Phase I trial of cancer drug
A monoclonal antibody targeting TIGIT in cancer patients, BAT6005 was discovered using the company’s IDEAL platform.
Philippines approves Sputnik V Covid-19 vaccine for emergency use
The Food and Drug Administration of the Philippines has given approval to Sputnik V Covid-19 vaccine for emergency use, as the country struggles with spike in infections.
Tonix reports positive Covid-19 vaccine results in TNX-1800-dosed primates
Tonix Pharmaceuticals has reported preliminary positive results after vaccinating primates with TNX-1800, a live modified horsepox virus vaccine for percutaneous administration designed to express the Spike protein of SARS-CoV-2 virus and to elicit a predominant T cell response.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Altimmune Covid-19 vaccine candidate prevents SARS-CoV-2 disease in studies
US-based Altimmune has reported that additional preclinical data on its single dose intranasal Covid-19 vaccine candidate, AdCOVID, showed 100% protection against lethal challenge from the SARS-CoV-2 virus, and reduction in viral replication.
WHO issues EUL for J&J’s single-shot Covid-19 vaccine
The World Health Organization (WHO) has issued Emergency Use Listing (EUL) for the single-dose Covid-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) for individuals aged 18 years and above.
AstraZeneca and Amgen report positive results from NAVIGATOR trial
AstraZeneca and Amgen have reported positive results from the NAVIGATOR Phase III trial for Tezepelumab, a potential drug in treating patients suffering with severe, uncontrolled asthma.
Five Prime Therapeutics reports positive results from Phase II FIGHT trial
Five Prime Therapeutics, a clinical-stage biotechnology company, has reported positive topline results from the global, randomised, double-blind placebo-controlled Phase II FIGHT trial.
Medicago reports interim results of Phase I trial of Covid-19 vaccine
Biopharmaceutical company Medicago has reported interim results of the Phase I clinical trial of the plant-derived vaccine for Covid-19.